Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only

Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only

Blend CJC-1295 no DAC + Ipamorelin

$86.90

Product Type: Multi-Component Research Peptide Blend

CJC-1295 No DAC

CAS #: Commonly referenced as 863288-34-0 for the modified GRF (1-29) form
Molecular Formula: Product-form dependent
Molecular Weight (M.W.): Approximately 3367 g/mol, depending on exact form
Sequence: YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH₂

Ipamorelin

CAS #: 170851-70-4
Molecular Formula: C₃₈H₄₉N₉O₅
Molecular Weight (M.W.): Approximately 711.85 g/mol
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

Blend Information

Blend CAS #: Not Applicable
Blend Formula: Not Applicable
Blend Molecular Weight: Not Applicable
Blend Sequence: Not Applicable

VIEW COA

Description

CJC-1295 No DAC + Ipamorelin Blend combines two distinct synthetic peptide research materials within a single formulation for controlled laboratory and analytical study.

CJC-1295 No DAC is commonly referred to as a modified growth hormone-releasing factor analogue that lacks the Drug Affinity Complex component associated with DAC-containing variants. Ipamorelin is a short synthetic pentapeptide analogue with a distinct chemical structure and analytical profile.

Because the blend contains two separate molecular entities, do not assign one CAS Registry Number, molecular formula, molecular weight, or sequence to the combined product. Document each component independently.

Research Context

This blend may be examined in non-clinical experimental systems involving peptide chemistry, molecular signaling, receptor-related biochemical research, analytical characterization, and comparative peptide studies.

Any observations should remain specific to the experimental model being used. They should not be interpreted as evidence of therapeutic effectiveness, clinical safety, or suitability for human use.

Analytical Identification

Accurate characterization of the blend should distinguish CJC-1295 No DAC and Ipamorelin independently.

Relevant analytical documentation may include:

  • Component identity
  • Blend ratio
  • Peptide purity
  • Molecular characterization
  • Chromatographic analysis
  • Mass-based analysis
  • Lot and batch information
  • Certificate of Analysis

Confirm the actual ratio of the two components directly from the product label or lot-specific Certificate of Analysis.

Specifications & Documentation

Product specifications may vary according to salt form, counter-ion, moisture content, and analytical basis. Lot-specific documentation should therefore take precedence over generic reference values.

For CJC-1295 No DAC in particular, naming conventions and molecular data can vary between suppliers depending on the exact modified GRF form represented.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Maintain appropriate laboratory controls and protect the material from environmental conditions that may affect peptide integrity.

Restrict handling to qualified research personnel following established laboratory procedures.

Research Use Only

This blend is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, medical, or clinical claims are made or implied. All information is supplied solely for scientific identification, documentation, and research reference.

Additional information

dose

5mg + 5mg

Reviews

There are no reviews yet.

Be the first to review “Blend CJC-1295 no DAC + Ipamorelin”

Your email address will not be published. Required fields are marked *